Global Respiratory Devices Market - Growth, Trends & Forecasts (2017 - 2022)

The global respiratory devices market for the period 2016-2021 is expected to account for USD XX billion in 2021, growing at a CAGR of XX% from USD XX billion in 2016. Respiratory therapy in India is a medical specialty focused on the treatment, management, control, diagnostic evaluation and care of patients with deficiencies of the cardiopulmonary system.

Respiratory devices help in the removal of mucus from the respiratory airways and thereby improve pulmonary function. As a result of its high propensity for respiratory diseases, India is expected to be viewed as a potential target for global medical device makers.

Global Respiratory Devices Market- Market Dynamics

The report details several driving and restraining factors for the global respiratory devices market. Some of these are listed below.


Increase in the number of patients suffering from respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD), tuberculosis, asthma and pneumonia

Technological advancements in the development of better devices

Increase in disposable incomes

Increase in the demand for respiratory devices in private hospitals and clinics


Increase in sophistication of devices

High costs associated with the purchase and operation

Lack of public awareness, especially in developing countries

The global respiratory devices market can be segmented based on diagnostic services, therapeutics, disposables, and geography.

Based on diagnostic services, the market can be further segmented into spirometers, sleep test devices, peak flow meters, pulse oximeter, and capnograph.

Based on therapeutic devices, the market can be segmented into CPAP devices, BI-PAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, and resuscitators.

Based on the type of disposable, the market is further segmented into masks, cannulas, tubes, filters and breathing circuit.

Based on geography, the market is segmented into North America, Europe, Asia-Pacific, Africa & Middle East and Latin America.

Some of the key players in the market are:


AstraZeneca PLC

GE Healthcare



Philips Healthcare

Key Deliverables in the Study

Market analysis for the respiratory devices market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market.

Identification and analysis of the macro and micro factors that affect the respiratory devices market on the global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.


1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and forecast period years

1.6 General Study Assumptions

1.7 Report Description


2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric forecast models

2.4 Research Assumptions



4.1 Current market scenario

4.2 Porters Five Force Analysis

4.2.1 Bargaining Power of suppliers

4.2.2 Bargaining power of buyers

4.2.3 Degree of competition

4.2.4 Threat of substitution

4.2.5 Threat of new entrants


5.1 Market Drivers

5.1.1 Rise in the number of Chronic Obstructive Pulmonary Disease patients (COPD), TB, and Asthma and Pneumonia cases

5.1.2 Technological advancements in the device

5.1.3 Increased disposable income

5.2 Market Restraints

5.2.1 Cost and operational difficulty for the use of device

5.2.2 Increased sophistication in the usage of the device

5.3 Market Opportunities

5.3.1 Increase in the number of private clinics and hospitals

5.4 Key Challenges

5.4.1 Lack of public awareness

6. 6. Global Respiratory device Market Segmentation

6.1 By Type

6.1.1 by diagnostic and monitoring devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeter Capnographs

6.1.2 by therapeutic devices CPAP Devices BI-PAP Devices Humidifiers Nebulizers Oxygen Concentrators Ventilators Inhalers Resuscitators

6.1.3 by Disposables Masks Cannulas Tubes Filters Breathing Circuits

6.2 By Geography

6.2.1 North America USA Canada Mexico

6.2.2 Europe France UK Germany Spain and Portugal Italy Rest of Europe

6.2.3 Asia-Pacific Introduction India China Japan South Korea Australia and New Zealand Rest of Asia-Pacific

6.2.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa

6.2.5 Latin America Brazil Argentina Rest of Latin America


7.1 Mergers & Acquisitions

7.2 New Product Launches

7.3 Agreements, Collaborations & Partnerships


8.1 GE Healthcare

8.2 Resmed Inc.

8.3 Chart Industries Inc.

8.4 AstraZeneca PLC

8.5 Medtronic

8.6 3M

8.7 Airsep Corp

8.8 Dragerwerk AG

8.9 GlaxoSmithKline

8.10 Invacare

8.11 Philips Healthcare

8.12 Teleflex Inc

8.13 Intersurgical Ltd

8.14 Bomimed Inc

8.15 Covidien PLC

9. Future outlook of the market

Content are not available

Choose License Type